Interleukin 6‐blockade treatment for severe COVID‐19 in two patients with multiple myeloma

Saved in:
Bibliographic Details
Published inBritish journal of haematology Vol. 190; no. 1; pp. e9 - e11
Main Authors Chaidos, Aristeidis, Katsarou, Alexia, Mustafa, Chira, Milojkovic, Dragana, Karadimitris, Anastasios
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.07.2020
Subjects
Aged
Antibodies, Monoclonal, Humanized - administration & dosage
Betacoronavirus
Coronavirus Infections - drug therapy
COVID-19
cytokine release syndrome
Hematology
Humans
Immunosuppressive agents
Interleukin 6
Interleukin-6 - antagonists & inhibitors
Male
Middle Aged
Multiple myeloma
Multiple Myeloma - drug therapy
Multiple Myeloma - virology
myeloma
Neoplasm Proteins - administration & dosage
Pandemics
Pneumonia, Viral - drug therapy
SARS-CoV-2
Severity of Illness Index
tocilizumab
COVID-19
tocilizumab
myeloma
cytokine release syndrome
interleukin-6
Online AccessGet full text
ISSN0007-1048
1365-2141
1365-2141
DOI10.1111/bjh.16787

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Correspondence-1
ISSN:0007-1048
1365-2141
1365-2141
DOI:10.1111/bjh.16787